InterCure Ltd.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.8% | -29.8% | -2.6% | -31.5% | -75.2% | – | – | – | – | +628.6% | +237.8% | +76.9% | -8.5% | -32.8% | +13.1% | |
| – | -7.5% | -31.0% | -7.7% | +1.7% | -71.2% | – | – | – | – | +343.9% | +288.8% | +81.7% | +7.2% | -16.7% | +13.6% | |
| – | -9.1% | -29.4% | -1.0% | -41.1% | -77.2% | – | – | – | – | +2,061.9% | +185.0% | +70.2% | -32.2% | -71.2% | +9.8% | |
| – | -17.9% | -58.4% | -70.3% | -51.5% | – | – | – | – | – | -7.8% | -21.6% | -48.8% | -38.6% | +6.7% | -5.8% | |
| – | -39.8% | -12.6% | -36.1% | +9.9% | -36.3% | -30.8% | -20.1% | +776.7% | +708.0% | -74.2% | +121.7% | +102.5% | -29.9% | -2.1% | -4.4% | |
| – | -27.3% | -21.2% | -3.5% | -22.7% | -47.7% | -58.5% | -20.1% | +776.7% | -50.1% | +1,338.0% | -10.6% | +65.9% | +40.4% | -33.6% | -72.9% | |
| – | – | – | – | – | – | – | -430.8% | – | – | – | – | +79.6% | -182.1% | – | – | |
| – | -19.6% | -74.1% | -95.3% | +25.7% | +89.8% | +98.9% | +55.4% | +60.4% | +92.2% | -73.2% | +855.5% | +191.2% | +64.9% | -14.8% | -4.8% | |
| – | – | – | -115.2% | – | – | – | -2,081.4% | – | – | – | – | +134.0% | -239.8% | – | – | |
| – | -9.2% | +4,273.5% | -95.2% | -100.0% | – | – | -78.3% | -273.2% | – | – | – | -99.2% | +2,317.2% | -746.4% | – | |
| – | – | – | -115.2% | – | – | – | -2,081.4% | – | – | – | – | +855.6% | -238.2% | – | – | |
| – | – | +8,238.7% | -114.0% | – | – | – | – | – | – | – | – | +125.3% | -134.0% | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.